These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12651002)

  • 1. Expression and purification of Plasmodium falciparum MSP-1(42): A malaria vaccine candidate.
    Epp C; Kauth CW; Bujard H; Lutz R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 786(1-2):61-72. PubMed ID: 12651002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.
    Pan W; Ravot E; Tolle R; Frank R; Mosbach R; Türbachova I; Bujard H
    Nucleic Acids Res; 1999 Feb; 27(4):1094-103. PubMed ID: 9927744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.
    O'Donnell RA; Saul A; Cowman AF; Crabb BS
    Nat Med; 2000 Jan; 6(1):91-5. PubMed ID: 10613831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate.
    Bonnet S; Pêtres S; Holm I; Fontaine T; Rosario S; Roth C; Longacre S
    Vaccine; 2006 Aug; 24(33-34):5997-6008. PubMed ID: 16814434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
    Daubenberger CA; Nickel B; Ciatto C; Grütter MG; Pöltl-Frank F; Rossi L; Siegler U; Robinson J; Kashala O; Patarroyo ME; Pluschke G
    Eur J Immunol; 2002 Dec; 32(12):3667-77. PubMed ID: 12516559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope analysis of human T-cell response to MSP-1 of Plasmodium falciparum in malaria-nonexposed individuals.
    Ohta N; Iwaki K; Itoh M; Fu J; Nakashima S; Hato M; Tolle R; Bujard H; Saitoh A; Tanabe K
    Int Arch Allergy Immunol; 1997 Sep; 114(1):15-22. PubMed ID: 9303326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.
    Woehlbier U; Epp C; Kauth CW; Lutz R; Long CA; Coulibaly B; Kouyaté B; Arevalo-Herrera M; Herrera S; Bujard H
    Infect Immun; 2006 Feb; 74(2):1313-22. PubMed ID: 16428781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.
    Angov E; Aufiero BM; Turgeon AM; Van Handenhove M; Ockenhouse CF; Kester KE; Walsh DS; McBride JS; Dubois MC; Cohen J; Haynes JD; Eckels KH; Heppner DG; Ballou WR; Diggs CL; Lyon JA
    Mol Biochem Parasitol; 2003 May; 128(2):195-204. PubMed ID: 12742586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of analytical methods for the evaluation of antibody responses against epitopes of polymorphic protein antigens.
    Helg A; Mueller MS; Joss A; Pöltl-Frank F; Stuart F; Robinson JA; Pluschke G
    J Immunol Methods; 2003 May; 276(1-2):19-31. PubMed ID: 12738356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
    Cheng XJ; Hayasaka H; Watanabe K; Tao YL; Liu JY; Tsukamoto H; Horii T; Tanabe K; Tachibana H
    Infect Immun; 2007 Jul; 75(7):3614-20. PubMed ID: 17452466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells.
    Urquiza M; Rodriguez LE; Suarez JE; Guzmán F; Ocampo M; Curtidor H; Segura C; Trujillo E; Patarroyo ME
    Parasite Immunol; 1996 Oct; 18(10):515-26. PubMed ID: 9226689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro.
    Nikodem D; Davidson E
    Mol Biochem Parasitol; 2000 Apr; 108(1):79-91. PubMed ID: 10802320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common cross-species function for the double epidermal growth factor-like modules of the highly divergent plasmodium surface proteins MSP-1 and MSP-8.
    Drew DR; O'Donnell RA; Smith BJ; Crabb BS
    J Biol Chem; 2004 May; 279(19):20147-53. PubMed ID: 14976193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C.
    Wu S; Beier M; Sztein MB; Galen J; Pickett T; Holder AA; Gómez-Duarte OG; Levine MM
    J Biotechnol; 2000 Sep; 83(1-2):125-35. PubMed ID: 11000468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The merozoite surface protein 1 complex of human malaria parasite Plasmodium falciparum: interactions and arrangements of subunits.
    Kauth CW; Epp C; Bujard H; Lutz R
    J Biol Chem; 2003 Jun; 278(25):22257-64. PubMed ID: 12654909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.
    Sachdeva S; Ahmad G; Malhotra P; Mukherjee P; Chauhan VS
    Infect Immun; 2004 Oct; 72(10):5775-82. PubMed ID: 15385477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel strategy for the synthesis of the cysteine-rich protective antigen of the malaria merozoite surface protein (MSP-1). Knowledge-based strategy for disulfide formation.
    Spetzler JC; Rao C; Tam JP
    Int J Pept Protein Res; 1994 Apr; 43(4):351-8. PubMed ID: 8045680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1.
    James S; Moehle K; Renard A; Mueller MS; Vogel D; Zurbriggen R; Pluschke G; Robinson JA
    Chembiochem; 2006 Dec; 7(12):1943-50. PubMed ID: 17068840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, purification and characterization of allelic variants of MSP-1(42) from Indian Plasmodium falciparum isolates.
    Lalitha PV; Biswas S; Pillai CR; Seth RK; Saxena RK
    Vaccine; 2010 Jun; 28(29):4661-7. PubMed ID: 20452429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
    Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
    Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.